Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Aug;56(2):147–152. doi: 10.1038/bjc.1987.174

Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.

M Brada 1, S Mizutani 1, H Molgaard 1, J P Sloane 1, J Treleaven 1, A Horwich 1, M J Peckham 1
PMCID: PMC2002151  PMID: 3311108

Abstract

We studied peripheral blood mononuclear cells from 50 patients with active B- and T-cell non-Hodgkin's lymphoma by DNA hybridisation. Nineteen patients (38%) had circulating clones of cells detected by immunoglobulin gene rearrangement (17 patients) or T-cell receptor gene rearrangement (2 patients) with JH and J beta 2 probes. Lymphoma tissue and peripheral blood were studied simultaneously in 22 patients, 9 of which had a circulating clone of cells in peripheral blood. In 7 patients the gene rearrangement in lymphoma tissue and peripheral blood mononuclear cells was identical. However, in 2 patients both heavy chain and light chain gene rearrangements were different in tissue and peripheral blood. The incidence of peripheral blood involvement was commonest in advanced CSIII & IV disease (54%) compared to CSI & II disease (18%) (P less than 0.05), and in low grade (45%) compared to intermediate and high grade lymphoma (31%) (difference not statistically significant). Only 4 patients had definite lymphoma cells seen on peripheral blood smear. The presence of circulating lymphoma cells correlated with conventional assessment of bone marrow involvement although circulating clones were detected in 30% (12/40) of patients with apparently normal bone marrow.

Full text

PDF
152

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold A., Cossman J., Bakhshi A., Jaffe E. S., Waldmann T. A., Korsmeyer S. J. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med. 1983 Dec 29;309(26):1593–1599. doi: 10.1056/NEJM198312293092601. [DOI] [PubMed] [Google Scholar]
  2. Bartl R., Frisch B., Burkhardt R., Kettner G., Mahl G., Fateh-Moghadam A., Sund M. Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification and staging. Br J Haematol. 1982 Aug;51(4):511–530. doi: 10.1111/j.1365-2141.1982.tb02815.x. [DOI] [PubMed] [Google Scholar]
  3. Bennett J. M., Cain K. C., Glick J. H., Johnson G. J., Ezdinli E., O'Connell M. J. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. J Clin Oncol. 1986 Oct;4(10):1462–1469. doi: 10.1200/JCO.1986.4.10.1462. [DOI] [PubMed] [Google Scholar]
  4. Berliner N., Ault K. A., Martin P., Weinberg D. S. Detection of clonal excess in lymphoproliferative disease by kappa/lambda analysis: correlation with immunoglobulin gene DNA rearrangement. Blood. 1986 Jan;67(1):80–85. [PubMed] [Google Scholar]
  5. Bertness V., Kirsch I., Hollis G., Johnson B., Bunn P. A., Jr T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29;313(9):534–538. doi: 10.1056/NEJM198508293130902. [DOI] [PubMed] [Google Scholar]
  6. Cabanillas F. Chemotherapy as definitive treatment of stage I-II large cell and diffuse mixed lymphomas. Hematol Oncol. 1985 Jan-Mar;3(1):25–31. doi: 10.1002/hon.2900030104. [DOI] [PubMed] [Google Scholar]
  7. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  8. Cleary M. L., Chao J., Warnke R., Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci U S A. 1984 Jan;81(2):593–597. doi: 10.1073/pnas.81.2.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cleary M. L., Galili N., Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med. 1986 Jul 1;164(1):315–320. doi: 10.1084/jem.164.1.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Come S. E., Jaffe E. S., Andersen J. C., Mann R. B., Johnson B. L., DeVita V. T., Jr, Young R. C. Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations. Am J Med. 1980 Nov;69(5):667–674. doi: 10.1016/0002-9343(80)90416-7. [DOI] [PubMed] [Google Scholar]
  11. Dick F., Bloomfield C. D., Brunning R. D. Incidence cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow. Cancer. 1974 May;33(5):1382–1398. doi: 10.1002/1097-0142(197405)33:5<1382::aid-cncr2820330525>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  12. Ford A. M., Molgaard H. V., Greaves M. F., Gould H. J. Immunoglobulin gene organisation and expression in haemopoietic stem cell leukaemia. EMBO J. 1983;2(6):997–1001. doi: 10.1002/j.1460-2075.1983.tb01533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gams R. A., Rainey M., Dandy M., Bartolucci A. A., Silberman H., Omura G. Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial. J Clin Oncol. 1985 Sep;3(9):1188–1195. doi: 10.1200/JCO.1985.3.9.1188. [DOI] [PubMed] [Google Scholar]
  14. Garrett J. V., Scarffe J. H., Newton R. K. Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphoma. Br J Haematol. 1979 May;42(1):41–50. doi: 10.1111/j.1365-2141.1979.tb03696.x. [DOI] [PubMed] [Google Scholar]
  15. Hu E., Trela M., Thompson J., Lowder J., Horning S., Levy R., Sklar J. Detection of B-cell lymphoma in peripheral blood by DNA hybridisation. Lancet. 1985 Nov 16;2(8464):1092–1095. doi: 10.1016/s0140-6736(85)90686-5. [DOI] [PubMed] [Google Scholar]
  16. Jaffe E. S. Follicular lymphomas: possibility that they are benign tumors of the lymphoid system. J Natl Cancer Inst. 1983 Mar;70(3):401–403. [PubMed] [Google Scholar]
  17. Johnson A., Cavallin-Ståhl E., Akerman M. Flow cytometric light chain analysis of peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma. Br J Cancer. 1985 Aug;52(2):159–165. doi: 10.1038/bjc.1985.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kleinfield R., Hardy R. R., Tarlinton D., Dangl J., Herzenberg L. A., Weigert M. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. 1986 Aug 28-Sep 3Nature. 322(6082):843–846. doi: 10.1038/322843a0. [DOI] [PubMed] [Google Scholar]
  19. Ligler F. S., Smith R. G., Kettman J. R., Hernandez J. A., Himes J. B., Vitetta E. S., Uhr J. W., Frenkel E. P. Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess". Blood. 1980 May;55(5):792–801. [PubMed] [Google Scholar]
  20. McKenna R. W., Bloomfield C. D., Brunning R. D. Nodular lymphoma: bone marrow and blood manifestations. Cancer. 1975 Aug;36(2):428–440. doi: 10.1002/1097-0142(197508)36:2<428::aid-cncr2820360218>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  21. Miller T. P., Jones S. E. Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood. 1983 Aug;62(2):413–418. [PubMed] [Google Scholar]
  22. O'Connor N. T., Wainscoat J. S., Weatherall D. J., Gatter K. C., Feller A. C., Isaacson P., Jones D., Lennert K., Pallesen G., Ramsey A. Rearrangement of the T-cell-receptor beta-chain gene in the diagnosis of lymphoproliferative disorders. Lancet. 1985 Jun 8;1(8441):1295–1297. doi: 10.1016/s0140-6736(85)92791-6. [DOI] [PubMed] [Google Scholar]
  23. Paryani S. B., Hoppe R. T., Cox R. S., Colby T. V., Rosenberg S. A., Kaplan H. S. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II. Cancer. 1983 Dec 15;52(12):2300–2307. doi: 10.1002/1097-0142(19831215)52:12<2300::aid-cncr2820521224>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  24. Ravetch J. V., Siebenlist U., Korsmeyer S., Waldmann T., Leder P. Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes. Cell. 1981 Dec;27(3 Pt 2):583–591. doi: 10.1016/0092-8674(81)90400-1. [DOI] [PubMed] [Google Scholar]
  25. Reth M., Gehrmann P., Petrac E., Wiese P. A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. 1986 Aug 28-Sep 3Nature. 322(6082):840–842. doi: 10.1038/322840a0. [DOI] [PubMed] [Google Scholar]
  26. Smith B. R., Weinberg D. S., Robert N. J., Towle M., Luther E., Pinkus G. S., Ault K. A. Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma. N Engl J Med. 1984 Dec 6;311(23):1476–1481. doi: 10.1056/NEJM198412063112304. [DOI] [PubMed] [Google Scholar]
  27. Sobol R. E., Dillman R. O., Collins H., Griffiths J. C., Green M. R., Royston I. Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphoma. Cancer. 1985 Oct 15;56(8):2005–2010. doi: 10.1002/1097-0142(19851015)56:8<2005::aid-cncr2820560820>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  28. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  29. Steward W. P., Todd I. D., Harris M., Jones J. M., Blackledge G., Wagstaff J., Anderson H., Wilkinson P. M., Crowther D. A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol. 1984 Jul;20(7):881–889. doi: 10.1016/0277-5379(84)90159-7. [DOI] [PubMed] [Google Scholar]
  30. Sutcliffe S. B., Gospodarowicz M. K., Bush R. S., Brown T. C., Chua T., Bean H. A., Clark R. M., Dembo A., Fitzpatrick P. J., Peters M. V. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol. 1985 Nov;4(3):211–223. doi: 10.1016/s0167-8140(85)80086-4. [DOI] [PubMed] [Google Scholar]
  31. Toyonaga B., Yoshikai Y., Vadasz V., Chin B., Mak T. W. Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8624–8628. doi: 10.1073/pnas.82.24.8624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Weinberg D. S., Pinkus G. S., Ault K. A. Cytofluorometric detection of B cell clonal excess: a new approach to the diagnosis of B cell lymphoma. Blood. 1984 May;63(5):1080–1087. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES